Medifast, Inc. (MED)

NYSE: MED · USD

$12.6

+0.06 (+0.5%)· Recorded snapshot

Market cap	131M
Revenue (ttm)	299.6M
Net income (ttm)	-40.9M
EPS (ttm)	-$3.69
Shares out	10.4M
Volume	123,785.013
Beta	0.70

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 299.6M
Net income (ttm): -40.9M
EPS (ttm): -$3.69
Market cap: 131M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABNB	Airbnb, Inc.	98.4B	37.8x	7.5x	16.8%	+24.4%	+31.9%	Sell
AMZN	Amazon.com Inc.	2.7T	20.3x	3.4x	10.9%	+11.7%	+2.6%	Sell
APTV	Aptiv PLC	8.6B	11.5x	0.4x	11.7%	+5.6%	-49.0%	Buy

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-20.7

P25 n/aP50 n/aP75 n/a

ROIC-84.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All MED indicators

Market & fundamental data

Available fields

222

Groups with data

Currency

USD

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000910329
Company name	Medifast, Inc.
Country	United States
Country code	US
CUSIP number	58470H101
Earnings date	2026-10-26
Earnings time	bmo
Employees	380
Employees change	-124
Employees growth	-24.6%
Enterprise value	$-20.9M
Exchange	NYSE
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-09
Fiscal year end	December
Founded	1980
Industry	Personal Services
Is primary listing	Yes
Is SPAC	No
ISIN number	US58470H1014
Last 10-K release date	2026-02-17
Last earnings date	2026-10-26
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$131M
Market cap category	Micro-Cap
Next earnings date	2027-02-16
Options	Yes
Price	$12.59
Price currency	USD
Sector	Consumer Discretionary
SIC code	2090
Stock price date	2026-11-03
Symbol	MED
U.S. state	Maryland
Website	https://medifastinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	37.95x
Average P/E ratio (5Y)	54.9x
Earnings yield	-29.31%
FCF / EV yield	18.55%
FCF yield	-2.95%
Forward P/S	0.48x
Industry forward P/E	18.54x
Industry P/E	25.92x
P/B ratio	0.73x
P/S ratio	0.44x
Price / tangible book value	0.73x
Sector forward P/E	23.56x
Sector P/E	30x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-11.61%
EBITDA margin	-7.35%
Gross margin	69.21%
Operating margin	-11.61%
Pretax margin	-9.73%
Profit margin	-13.64%
Profit per employee	$-107,505
Revenue per employee	$788,347
ROA	-8.56%
ROA (5Y)	19.51%
ROCE	-17.58%
ROE	-20.69%
ROE (5Y)	43.83%
ROIC	-84.22%
ROIC (5Y)	73.01%
SBC / revenue	2.58%
Tax / revenue	3.91%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth (Q)	-73.32%
FCF growth (QoQ)	293.96%
Gross profit growth	-33.39%
Gross profit growth (Q)	-19.5%
Gross profit growth 3Y	-38.24%
Gross profit growth 5Y	-27.69%
Net income growth years	0
OCF growth (Q)	-72.8%
OCF growth (QoQ)	94.17%
Revenue growth	-30.28%
Revenue growth (Q)	-19.42%
Revenue growth (QoQ)	-5.68%
Revenue growth 10Y	0.92%
Revenue growth 3Y	-37.35%
Revenue growth 5Y	-26.67%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-3.8M
Depreciation and amortization	$12.8M
EBIT	$-34.8M
EBITDA	$-22M
EPS	$-3.69
FCF per share	$-0.37
Financing cash flow	$-994,000
Free cash flow	$-3.9M
Free cash flow minus SBC	$-11.6M
Gross profit	$207.3M
Income taxes	$11.7M
Investing cash flow	$-40.1M
Net cash flow	$-41.2M
Net income	$-40.9M
Operating cash flow minus SBC	$-7.8M
Operating income	$-34.8M
Revenue	$299.6M
Stock-based compensation	$7.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.55
Book value per share	$17.33
Debt / equity	0.11
Long-term assets	$37.8M
Long-term liabilities	$17.6M
Net cash (debt)	$151.8M
Net cash / market cap	115.92%
Net cash growth	-5.83%
Net debt / equity	-0.84
Piotroski F-Score	2
Property, plant and equipment	$32.7M
Shareholders' equity	$180.3M
Tangible book value	$180.3M
Tangible book value per share	$17.33
Total assets	$239.8M
Total cash	$172.5M
Total debt	$20.7M
Total liabilities	$59.5M
WACC	6.99%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.18
Current assets	$201.9M
Current liabilities	$41.9M
Current ratio	4.82
Inventory turnover	4.15
Net working capital	$-9.4M
Quick ratio	4.12
Working capital	$160.1M
Working capital turnover	1.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.94%
Dividend growth (3Y)	13.39%
Dividend growth (5Y)	27.97%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$1.65
Shareholder yield	-0.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-68.94%
10Y return CAGR	-8.81%
10Y total return	-60.24%
150-day SMA	$11.54
15Y price change	-18.19%
15Y return CAGR	0.52%
15Y total return	8.07%
1D price change	0.48%
1M price change	7.33%
1M total return	7.33%
1W price change	0.8%
1W total return	0.8%
1Y price change	4.74%
1Y return CAGR	4.75%
1Y total return	4.74%
20-day SMA	$12.01
200-day SMA	$11.33
20Y price change	49.7%
20Y return CAGR	3.47%
20Y total return	97.76%
3M price change	28.08%
3M total return	28.08%
3Y price change	-81.72%
3Y return CAGR	-43.24%
3Y total return	-81.72%
50-day SMA	$12.01
50-day SMA vs 200-day SMA	50over200
52-week high	$13.45
52-week high date	2026-08-04
52-week low	$9.22
52-week low date	2026-03-13
5Y price change	-94.07%
5Y return CAGR	-41.9%
5Y total return	-93.38%
6M price change	15.4%
6M total return	15.4%
All-time high	$336.99
All-time high date	2021-05-28
All-time low	$0.09
All-time low date	1999-12-23
Average true range (ATR)	$0.44
Average volume	135.6K
Beta (1Y)	1.75
Beta (2Y)	1.18
Beta (5Y)	0.7
Change from 52-week high	-6.39%
Change from 52-week low	36.55%
Change from all-time high	-96.26%
Change from all-time low	13,322.17%
Change from open	-0.16%
Day's gap	0.64%
Dollar volume	$1.6M
High price	$12.85
Low price	$12.51
Monthly RSI	33.98
Open price	$12.61
Position in 52-week range	23.53%
Previous close	$12.53
Price vs 150-day SMA	9.07%
Price vs 20-day SMA	4.83%
Price vs 200-day SMA	11.17%
Price vs 50-day SMA	4.81%
Relative volume	0.91
RSI	62.6
Sharpe ratio	0.25
Sharpe ratio (3Y)	-0.97
Sharpe ratio (5Y)	-0.97
Sortino ratio	0.68
Sortino ratio (3Y)	-1.28
Sortino ratio (5Y)	-1.23
Volume	123.8K
Weekly RSI	56.96
YTD price change	17.88%
YTD total return	17.88%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8.5M
Float percentage	81.88%
Shares change (QoQ)	0.41%
Shares change (YoY)	0.94%
Shares held by insiders	3.59%
Shares held by institutions	63.92%
Shares outstanding	10.4M
Short % of float	13.59%
Short % of shares	11.13%
Short ratio	9.6 days

Deeper analysis on MED

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MED report

Is a complete MED research report available?

No complete published report is available for Medifast, Inc. (MED) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Medifast, Inc. (MED)

Price

Financial snapshot

Fair-value bridge

Latest news · MED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MED indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MED

Frequently asked questions